Eargo (NASDAQ: EAR) is an audio hardware company focusing on the hearing experience. The company's hearing devices are designed to be 'virtually invisible', utilizing Flexi Fibers to suspend the device in the ear canal and keep it hidden while leaving the ear canal open to let natural bass sounds pass through. Eargo was founded in 2010 and is based in San Jose, California.
Missing: Eargo's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Eargo's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Eargo
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Eargo in 1 CB Insights research brief, most recently on Mar 12, 2020.
Expert Collections containing Eargo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eargo is included in 7 Expert Collections, including Wearable Computing.
Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Smart Home & Consumer Electronics
This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Eargo has filed 24 patents.
Hearing, Acoustics, Binaural recordings, Sensors, MIDI
Hearing, Acoustics, Binaural recordings, Sensors, MIDI
Latest Eargo News
Jan 17, 2023
January 17, 2023 16:01 ET San Jose, California, UNITED STATES SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that it has filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the previously announced 1-for-20 reverse stock split of the Company’s common stock (the “Reverse Stock Split”). The Company’s common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Stock Market LLC (“Nasdaq”) at market open on January 18, 2023. The Company’s common stock will continue to trade on Nasdaq under the trading symbol “EAR”, but will trade under the following new CUSIP number: 270087208. As a result of the Reverse Stock Split, every 20 shares of common stock issued and outstanding as of the effective time of the Amendment will be automatically reclassified into one share of common stock. The Reverse Stock Split affects all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s common stock, except to the extent that the Reverse Stock Split results in some stockholders owning a fractional share. No fractional shares will be issued as a result of the Reverse Stock Split. Stockholders of record who would otherwise be entitled to receive a fractional share are entitled to a cash payment in lieu of such fractional share. As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise or vesting of all outstanding stock options and restricted stock unit awards, which will result in a proportional decrease in the number of shares of the Company’s common stock reserved for issuance upon exercise or vesting of such stock options and restricted stock unit awards, and, in the case of stock options, a proportional increase in the exercise price of all such stock options. In addition, the number of shares reserved for issuance under the Company’s equity plans immediately prior to the effective time of the Amendment will be reduced proportionately. The par value of the common stock will remain unchanged at $0.0001 per share after the Reverse Stock Split, and the number of authorized shares of common stock will remain at 450 million shares. About Eargo Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online, at retail locations or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. Eargo hearing aids are offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States. Related Links
Eargo Frequently Asked Questions (FAQ)
When was Eargo founded?
Eargo was founded in 2010.
Where is Eargo's headquarters?
Eargo's headquarters is located at 1600 Technology Drive, San Jose.
What is Eargo's latest funding round?
Eargo's latest funding round is Acq - Fin.
How much did Eargo raise?
Eargo raised a total of $231.11M.
Who are the investors of Eargo?
Investors of Eargo include Patient Square Capital, Maveron, New Enterprise Associates, Pivotal bioVenture Partners, Longitude Capital and 16 more.
Who are Eargo's competitors?
Competitors of Eargo include hearX Group.
Compare Eargo to Competitors
Alethea Medical is an e-consultation and digital diagnostics platform that is built for family physicians. The company creates technology that provides physicians with AI predictive support for ear, nose, and throat conditions, including e-consultation for expedited specialist communication. Its clients are healthcare professionals. The company was formerly known as ENTiD and changed it's name to Alethea Medical. It was founded in 2018 and is based in Calgary, Alberta.
MDHearingAid is a Midwest company that provides affordable hearing aids that are high-quality, FDA-registered medical devices programmed to the highest standards and tested by an in-house team of audiologists and hearing professionals. It is based in Chicago, Illinois.
Audicus is an eCommerce startup that offers discreet, cost-effective, designer hearing aids. Its products combine seemingly invisible design with high-tech sound technology and are fully customizable.
hearX Group has created hearScreen, hearZA, mHealth Studio, hearTest and hearDigits, as well as a partner product in vision called Peek Vision. These products are made to help healthcare providers detect hearing problems in patients.
Lively offers modern hearing aids that pair with smartphones and tablets. iPhone and iPad users can stream calls and music to Lively hearing devices via Bluetooth. The Lively mobile app pairs with Lively hearing aids so clients can discreetly control volume and select presets for the office, restaurants, traffic, and other environments. It is based in New York. On December 14th, 2021, GN Group acquired a majority stake in Lively at a valuation of $94.8M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.